We are live on ! Find out more
LTFS

Ladenburg Thalmann Financial Services Portfolio holdings

AUM $15.9B
1-Year Est. Return 27.61%
This Fund
S&P 500
This Quarter Est. Return
+3.16%
1 Year Est. Return
+27.61%
3 Year Est. Return
+43.58%
5 Year Est. Return
+60.23%
10 Year Est. Return
AUM
$13.8B
AUM Growth
+$745M
Cap. Flow
+$378M
Cap. Flow %
2.73%
Top 10 Hldgs %
13.62%
Holding
5,637
New
274
Increased
2,376
Reduced
1,854
Closed
150

Sector Composition

Rank Sector Weight
1 Technology 7.03%
2 Financials 5.66%
3 Industrials 4.08%
4 Consumer Discretionary 3.92%
5 Healthcare 3.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
USLV
5201
DELISTED
VelocitySharesTM 3x Long Silver ETN linked to the S&P GSCI Silver Index ER
USLV
$1K ﹤0.01%
8
VIA
5202
DELISTED
Viacom Inc. Class A
VIA
$1K ﹤0.01%
40
-224
-85% -$7.75K
NTP
5203
DELISTED
Nam Tai Property Inc.
NTP
$1K ﹤0.01%
70
MBT
5204
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
$1K ﹤0.01%
162
+12
+8% +$98
VVUS
5205
DELISTED
Vivus Inc
VVUS
$1K ﹤0.01%
245
-85
-26% -$312
AUO
5206
DELISTED
AU Optronics Corp
AUO
$1K ﹤0.01%
355
-5,961
-94% -$19.3K
AXJV
5207
DELISTED
iShares Edge MSCI Min Vol Asia ex Japan ETF
AXJV
$1K ﹤0.01%
40
PRMW
5208
DELISTED
Primo Water Corporation
PRMW
$1K ﹤0.01%
+60
New +$807
GCVRZ
5209
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$1K ﹤0.01%
2,463
+170
+7% +$85
ABEO icon
5210
Abeona Therapeutics
ABEO
$425M
$0 ﹤0.01%
4
ACHV icon
5211
Achieve Life Sciences
ACHV
$685M
-19
Closed -$1.34K
ACMR icon
5212
ACM Research
ACMR
$5.53B
$0 ﹤0.01%
+18
New +$104
ACRS icon
5213
Aclaris Therapeutics
ACRS
$868M
-22
Closed
ACTG icon
5214
Acacia Research
ACTG
$465M
$0 ﹤0.01%
148
ADAP
5215
DELISTED
Adaptimmune Therapeutics
ADAP
-500
Closed -$2K
ADTN icon
5216
Adtran
ADTN
$622M
$0 ﹤0.01%
+24
New +$383
ALT icon
5217
Altimmune
ALT
$593M
$0 ﹤0.01%
1
AMR icon
5218
Alpha Metallurgical Resources
AMR
$1.95B
$0 ﹤0.01%
10
-20
-67% -$1.11K
ANIK icon
5219
Anika Therapeutics
ANIK
$277M
-180
Closed -$5K
AQST icon
5220
Aquestive Therapeutics
AQST
$538M
$0 ﹤0.01%
+100
New +$512
AREC icon
5221
American Resources Corp
AREC
$305M
-6,000
Closed -$25K
ARMP icon
5222
Armata Pharmaceuticals
ARMP
$169M
$0 ﹤0.01%
52
-2
-4% -$8
ASRV icon
5223
AmeriServ Financial
ASRV
$87.5M
$0 ﹤0.01%
+37
New +$153
AUDC icon
5224
AudioCodes
AUDC
$255M
$0 ﹤0.01%
+7
New +$107
AVD icon
5225
American Vanguard Corp
AVD
$65.5M
$0 ﹤0.01%
+10
New +$153

Similar funds

Ladenburg Thalmann Financial Services's Q2 2019 Portfolio in Review

As of Q2 2019, Ladenburg Thalmann Financial Services held 5,637 positions worth $13.8B, up 5.7% from $13.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Ladenburg Thalmann Financial Services's Q2 2019 filing shows 274 new, 2,376 increased, 1,854 reduced and 150 closed positions. Its largest new stake was Dow Inc: 126,893 shares worth $6.23M. The largest sale was Invesco S&P 500 High Beta ETF, an estimated $34.4M.

By sector, the portfolio is most concentrated in Technology at 7% of assets, down from 7.3% a quarter earlier, followed by Financials and Industrials.

  • Ladenburg Thalmann Financial Services's largest Q2 2019 buy was Dow Inc: 126,893 shares worth $6.23M.
  • Ladenburg Thalmann Financial Services added most to iShares 7-10 Year Treasury Bond ETF in Q2 2019, an estimated $63.6M increase.
  • Ladenburg Thalmann Financial Services's biggest Q2 2019 reduction was Invesco S&P 500 High Beta ETF, cutting an estimated $34.4M.
  • Ladenburg Thalmann Financial Services fully exited IQ Enhanced Core Plus Bond U.S. ETF in Q2 2019, selling an estimated $5M.
  • Ladenburg Thalmann Financial Services's ten largest holdings make up 14% of its $13.8B portfolio in Q2 2019.
  • Ladenburg Thalmann Financial Services opened 274 new positions and closed 150 in Q2 2019.
  • Ladenburg Thalmann Financial Services's portfolio value rose 5.7% quarter-over-quarter to $13.8B.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q2 2019, filed 15 Aug 2019.